Celiac Disease

Earlier detection of celiac disease in children through mass screening or case-finding was “highly cost-effective” and improved long-term health outcomes vs. current practices, according to a study conducted in the Netherlands.

Tofacitinib “should be considered as a treatment option” for patients with refractory celiac disease type 2 who previously failed treatment with therapies such as budesonide, according to data in Clinical Gastroenterology and Hepatology.

In honor of International Celiac Awareness Day, landmarks in the U.S. and around the globe will once again light up on May 16 to promote the #ShineALightOnCeliac social media campaign to encourge awareness and additional research.

Children diagnosed with celiac disease and treated through a statewide screening program experienced improvements in initially unrecognized symptoms and quality of life, as well as greater adherence to a gluten-free diet, research showed.

The White House has accepted a $25,000 commitment from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, which will help advance the administration’s goal to end hunger and nutrition disparities by 2030.

Zonulin levels rise significantly in children in the months preceding a diagnosis of celiac disease autoimmunity, suggesting it could be used as a biomarker to screen at-risk children for celiac disease, researchers reported in Pediatrics.

VANCOUVER, British Columbia — Women with celiac disease had statistically higher odds of experiencing ovarian dysfunction, irregular menstruation, infertility and other women’s health disorders, according to a presenter.

High levels of serum anti-tissue transglutaminase IgA predicted duodenal villous atrophy and could be a reliable measure to avoid biopsy in the diagnosis of adult patients with suspected celiac disease, according to researchers.

In this Healio video exclusive, Imad Absah, MD, explains how an artificial intelligence-based algorithm helped accurately identify pediatric patients with known celiac disease, especially those who had not received adequate follow-up care.